Rhythm Biosciences Ltd ('RHY', the 'Company' or the 'Group') (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, demonstrating high sensitivity for both malignant and advanced precancerous lesions ...
9d
Rhythm Biosciences enhances geneType colorectal cancer test with clinical and lifestyle risk factors
Rhythm Biosciences has materially improved the predictive accuracy of its geneType colorectal cancer risk assessment clinical ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback